Laura E. Niklason is CEO & President +1 at Humacyte, Inc. (HUMA). They have made 23 open-market trades across 1 company since 2021, most recently 2025-08-20.
CIK 0001878075
8 open-market purchases totalling $15.4M since 2021, against 15 sales. Across 8 scored buys the stock is down 15.5% at ninety days, and 19.2 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| HUMA | 1,691,685 | $761K |
Shares reported on the most recent Form 4, priced at the 2025-08-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 38% | 13% |
| Avg Move | -1.0% | -9.7% | -15.5% |
| Alpha | -2.1% | -10.7% | -19.2% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HUMA | SELL | 2025-08-18 | 2025-08-20 | $1.67 | $7.5M | -4.4% | +17.7% | -24.1% |
| HUMA | BUY | 2024-11-19 | 2024-11-21 | $4.44 | $8K | +0.9% | +5.9% | -11.8% |
| HUMA | SELL | 2024-11-18 | 2024-11-20 | $4.40 | $13.2M | -4.9% | +3.8% | -16.1% |
| HUMA | SELL | 2024-09-09 | 2024-09-11 | $5.30 | $4.7M | -8.2% | +0.5% | -25.3% |
| HUMA | BUY | 2024-08-29 | 2024-09-03 | $6.55 | $8K | +0.2% | -6.2% | -21.0% |
| HUMA | SELL | 2024-08-27 | 2024-08-29 | $6.49 | $11.4M | -7.8% | -11.8% | -28.7% |
| HUMA | SELL | 2024-06-11 | 2024-06-13 | $7.20 | $7.0M | -28.6% | +20.0% | -18.7% |
| HUMA | BUY | 2024-06-04 | 2024-06-04 | $6.35 | $15K | +6.0% | -20.8% | -16.8% |
| HUMA | BUY | 2024-06-03 | 2024-06-03 | $7.37 | $15K | -2.2% | -23.0% | -24.8% |
| HUMA | SELL | 2024-05-31 | 2024-06-04 | $7.82 | $15.7M | +6.0% | -20.8% | -16.8% |
| HUMA | SELL | 2023-09-14 | 2023-09-15 | $2.78 | $5.6M | -12.7% | -23.3% | -8.0% |
| HUMA | SELL | 2023-08-17 | 2023-08-21 | $3.54 | $12.8M | +12.6% | -13.5% | -24.4% |
| HUMA | SELL | 2023-06-15 | 2023-06-16 | $3.12 | $1.6M | -6.5% | -4.6% | +9.6% |
| HUMA | SELL | 2023-06-13 | 2023-06-15 | $2.60 | $12.7M | -13.7% | -12.3% | +10.8% |
| HUMA | SELL | 2023-05-25 | 2023-05-26 | $2.75 | $7.2M | +10.4% | -24.7% | -5.7% |
| HUMA | SELL | 2022-12-16 | 2022-12-19 | $2.53 | $1.2M | -6.2% | +13.8% | +19.1% |
| HUMA | BUY | 2022-12-15 | 2022-12-19 | $2.54 | $25K | -6.2% | +13.8% | +19.1% |
| HUMA | SELL | 2022-12-13 | 2022-12-15 | $2.76 | $3.0M | -22.3% | -0.4% | +9.6% |
| HUMA | SELL | 2022-09-15 | 2022-09-19 | $4.00 | $6.1M | -12.7% | -17.1% | -42.6% |
| HUMA | BUY | 2022-09-15 | 2022-09-19 | $4.14 | $8K | -12.7% | -17.1% | -42.6% |
| HUMA | BUY | 2022-05-23 | 2022-05-25 | $4.83 | $48K | -3.9% | -32.7% | -13.8% |
| HUMA | SELL | 2021-12-14 | 2021-12-16 | $9.19 | $3.7M | -16.6% | -38.0% | -31.7% |
| HUMA | BUY | 2021-08-26 | 2021-08-27 | $10.00 | $15.2M | +10.1% | +2.2% | -12.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.